Advertisement

Topics

TcLand S.A. Company Profile

14:11 EDT 23rd June 2018 | BioPortfolio

Founded in 2002 as a spin-off of INSERM U643/ITERT, one of the first research and transplantation centers in the world, and initially supported by the local incubator Atlanpole, TcLand is a biopharmaceutical company, pioneer in personalised medicine in transplantation and auto-immune diseases. Originally specialised in analysis and monitoring of T cell immune responses, the company develops now specific diagnostic biomarkers as well as a proprietary portfolio of therapeutic molecules for grafted patients and patients with immune disorders such as multiple sclerosis.The company performs immunological tests (TcLandscape®) for pharmaceutical and biotechnology companies conducting clinical trials in oncology, auto-immune diseases, vaccination and transplantation.TcLand also conducts its own R&D with the development of new biomarkers (micro-arrays) and drug candidates, in close collaboration with INSERM U643 headed by Prof Jean-Paul Soulillou and with the support of INSERM Transfert Development. TcLand is a board member of the Atlantic Biotherapy Competitiveness Biocluster.

Location

CHU Hôtel Dieu30 Boulevard Jean Monnet
Nantes
44093
France

Contact

Phone: 33 (0)2 40 41 28 34
Fax: 33 (0)2 40 41 11 01
Email: contact@tcland-biotech.com


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

myoARRAY and TcLandscape Analysis for the Diagnosis of Inflammatory Myopathies

The diagnosis of the different forms of inflammatory myopathies (polymyositis, dermatomyositis, inclusion-body myositis...) remains difficult which may lead to unappropriate patient care. ...

Companies [1 Associated Companies listed on BioPortfolio]

TcLand S.A.

Founded in 2002 as a spin-off of INSERM U643/ITERT, one of the first research and transplantation centers in the world, and initially supported by the local incubator Atlanpole, TcLand is a biopharmac...

More Information about "TcLand S.A." on BioPortfolio

We have published hundreds of TcLand S.A. news stories on BioPortfolio along with dozens of TcLand S.A. Clinical Trials and PubMed Articles about TcLand S.A. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of TcLand S.A. Companies in our database. You can also find out about relevant TcLand S.A. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Transplantation
Organ transplantation is the moving of an organ from one body to another or from a donor site to another location on the patient's own body, for the purpose of replacing the recipient's damaged or absent organ. The emerging field of regenerative ...


Corporate Database Quicklinks



Searches Linking to this Company Record